Peter Lawson

Stock Analyst at Barclays

(1.06)
# 2229
Out of 5,441 analysts
144
Total ratings
Success rate
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
SDGR Schrodinger
Initiates Coverage On: Overweight
25
18.61 34.34% 1 Aug 14, 2025
REPL Replimune Group
Downgrades: Equal-Weight
17 3
4.98 -39.76% 4 Jul 23, 2025
EXEL Exelixis
Maintains: Equal-Weight
29 40
37.43 6.87% 6 Jul 10, 2025
MGNX Macrogenics
Maintains: Overweight
8 3
1.47 104.08% 9 May 14, 2025
FATE Fate Therapeutics
Maintains: Overweight
10 2
0.94 112.77% 4 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
1 1
n/a n/a 3 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 10
3.73 168.1% 3 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 4
1.97 103.05% 7 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
22 6
7 -14.29% 2 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
32 11
5.54 98.56% 1 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
32 16
6.58 143.16% 8 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
40 15
7.46 101.07% 2 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
63 47
46.99 0.02% 4 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
29 14
9.17 52.67% 7 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
11 3
1.52 97.37% 5 Apr 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 3
1.6 87.5% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 4
1.35 196.3% 1 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
54 60
34.71 72.86% 3 Sep 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 17
3.24 424.69% 5 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
32 33
12.5 164% 4 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
5
n/a n/a 4 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
92 66
31.9 106.9% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
75 105
129.46 -18.89% 10 Jul 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
20 31
9.64 221.58% 2 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
18 13
6.42 102.49% 1 May 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
9 26
25.59 1.6% 6 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
27 31
31.23 -0.74% 6 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 5
0.82 509.76% 4 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
175 50
n/a n/a 2 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
7 4
2.31 51.52% 4 Jul 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
355 365
94.79 285.06% 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
46
35.1 31.05% 2 Oct 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
40
n/a n/a 1 May 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
450
22.48 1901.78% 1 Mar 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
33
1.47 2144.9% 1 Mar 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
65 75
74.96 0.05% 2 Dec 4, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
49
n/a n/a 1 May 31, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
n/a n/a 1 Apr 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
19 5
n/a n/a 4 Apr 9, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
16 45
55.44 -18.83% 2 Jan 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
17 45
2.2 1945.45% 2 Jan 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Jan 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
70
n/a n/a 1 Jul 14, 2017